agile telehealth glp-1 HealthEquity offers care through | HealthEquity posted on the topic Agile Health Trust Review: Licensure,

, Dahl, A

Cardiovascular & Renal Benefits of GLP-1 Receptor Agonists Meta-analysis (2024) comprehensive review showing GLP-1RAs reduce major adverse cardiovascular events (MACE), all-cause mortality, stroke, and kidney-related outcomes, in patients with and without diabetes

Slow titration allows a gradual increase in the GLP-1RA dose, thereby helping to avoid nausea

M.CryanJ

If headaches align with dose escalation weeks, your provider may recommend delaying the next increase, reducing the increment size, or maintaining your current dose longer to allow adaptation

Those with kidney disease, previous kidney stones, or eye conditions face heightened risk and require baseline kidney and ophthalmology evaluation before attempting combination therapy